| Previous Close | 125.17 |
| Open | 125.26 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 800 |
| Day's Range | 124.09 - 125.54 |
| 52 Week Range | 87.68 - 132.30 |
| Volume | 4,678,190 |
| Avg. Volume | 4,751,988 |
| Market Cap | 168.202B |
| Beta (5Y Monthly) | 0.80 |
| PE Ratio (TTM) | 47.00 |
| EPS (TTM) | 2.66 |
| Earnings Date | Aug. 24, 2021 |
| Forward Dividend & Yield | 2.52 (2.01%) |
| Ex-Dividend Date | Jun. 24, 2021 |
| 1y Target Est | 140.12 |
- Zacks
Medtronic (MDT) Progresses in SCS With FDA Nod for Vanta
Vanta utilizes Medtronic's (MDT) proprietary AdaptiveStim technology for personalized pain relief.
- Zacks
Medtronic's (MDT) STROKE AF Trial Outcome Backs ICM Progress
STROKE AF trial shows Medtronic's (MDT) Reveal LINQ ICM has a seven-fold advantage in detecting AF compared to traditional standard of care in patients with large vessel or small vessel stroke.
- Zacks
Medtronic (MDT) Progresses in Neuromodulation on New FDA Nod
Medtronic's (MDT) SenSight claims to deliver patient-specific DBS therapy for the treatment of symptoms associated with Parkinson's, dystonia and essential tremor and medically refractory epilepsy.
© 2021 Verizon Media. All rights reserved.
